Cibc Asset Management Inc Eli Lilly & CO Transaction History

Cibc Asset Management Inc

$28.3 Billion
Q3 2024

A detailed history of Cibc Asset Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Cibc Asset Management Inc holds 206,050 shares of LLY stock, worth $160 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares

206,050

Previous 190,962 7.9%

Holding current value

$160 Million

Previous $173 Million 5.58%

% of portfolio

0.65%

Previous 0.67%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$772.14 - $960.02 $11.7 Million - $14.5 Million	15,088 Added 7.9%	206,050 $183 Million
Q2 2024 Aug 01, 2024	BUY	$724.87 - $909.04 $53.7 Million - $67.3 Million	74,028 Added 63.31%	190,962 $173 Million
Q1 2024 May 09, 2024	BUY	$592.2 - $792.28 $2.95 Million - $3.94 Million	4,979 Added 4.45%	116,934 $91 Million
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $2.86 Million - $3.37 Million	-5,438 Reduced 4.63%	111,955 $65.3 Million
Q3 2023 Oct 30, 2023	SELL	$434.7 - $599.3 $264,732 - $364,973	-609 Reduced 0.52%	117,393 $63.1 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $410,716 - $549,175	-1,171 Reduced 0.98%	118,002 $55.3 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $409,099 - $480,467	-1,317 Reduced 1.09%	119,173 $40.9 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $2.12 Million - $2.47 Million	6,602 Added 5.8%	120,490 $44.1 Million
Q3 2022 Nov 03, 2022	BUY	$296.48 - $337.87 $2.52 Million - $2.87 Million	8,498 Added 8.06%	113,888 $36.8 Million
Q2 2022 Aug 09, 2022	SELL	$278.73 - $327.27 $1.3 Million - $1.52 Million	-4,654 Reduced 4.23%	105,390 $34.2 Million
Q1 2022 May 06, 2022	BUY	$234.69 - $291.66 $6.13 Million - $7.61 Million	26,104 Added 31.1%	110,044 $31.5 Million
Q4 2021 Feb 08, 2022	BUY	$224.85 - $279.04 $782,253 - $970,780	3,479 Added 4.32%	83,940 $23.2 Million
Q3 2021 Nov 09, 2021	SELL	$221.6 - $272.71 $2.76 Million - $3.4 Million	-12,451 Reduced 13.4%	80,461 $18.6 Million
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $36.6 Million - $47.3 Million	-202,471 Reduced 68.55%	92,912 $21.3 Million
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $8.41 Million - $10.9 Million	-51,199 Reduced 14.77%	295,383 $55.2 Million
Q4 2020 Feb 03, 2021	BUY	$130.46 - $172.63 $1.52 Million - $2.01 Million	11,624 Added 3.47%	346,582 $58.5 Million
Q3 2020 Nov 05, 2020	BUY	$146.22 - $169.13 $18.7 Million - $21.7 Million	128,033 Added 61.87%	334,958 $49.6 Million
Q2 2020 Jul 28, 2020	BUY	$136.42 - $164.18 $16.6 Million - $20 Million	121,678 Added 142.74%	206,925 $34 Million
Q1 2020 Apr 30, 2020	BUY	$119.05 - $147.35 $488,105 - $604,135	4,100 Added 5.05%	85,247 $11.8 Million
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $548,285 - $679,101	-5,128 Reduced 5.94%	81,147 $10.7 Million
Q3 2019 Oct 30, 2019	SELL	$106.79 - $116.16 $110,634 - $120,341	-1,036 Reduced 1.19%	86,275 $9.65 Million
Q2 2019 Aug 05, 2019	SELL	$110.79 - $129.32 $477,172 - $556,981	-4,307 Reduced 4.7%	87,311 $9.67 Million
Q1 2019 May 06, 2019	SELL	$111.31 - $131.02 $777,055 - $914,650	-6,981 Reduced 7.08%	91,618 $11.9 Million
Q4 2018 Feb 12, 2019	SELL	$105.9 - $118.64 $315,476 - $353,428	-2,979 Reduced 2.93%	98,599 $11.4 Million
Q3 2018 Nov 02, 2018	SELL	$85.86 - $107.31 $74,612 - $93,252	-869 Reduced 0.85%	101,578 $10.9 Million
Q2 2018 Aug 09, 2018	BUY	$75.7 - $86.88 $221,422 - $254,124	2,925 Added 2.94%	102,447 $8.74 Million
Q1 2018 Apr 30, 2018	SELL	$74.21 - $87.6 $355,020 - $419,078	-4,784 Reduced 4.59%	99,522 $7.7 Million
Q4 2017 Feb 02, 2018	SELL	$81.94 - $87.89 $115,863 - $124,276	-1,414 Reduced 1.34%	104,306 $8.81 Million
Q3 2017 Nov 06, 2017	BUY	$77.07 - $85.54 $8.15 Million - $9.04 Million	105,720	105,720 $9.04 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $740B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.

Account

Cibc Asset Management Inc Eli Lilly & CO Transaction History